Literature DB >> 9712597

The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study.

H Nazerali1, H V Hogerzeil.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9712597      PMCID： PMC28644          DOI： 10.1136/bmj.317.7157.512

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Stability of essential drugs in Sudan.

Authors:  H V Hogerzeil; M J de Goeje; I O Abu-Reid
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

Review 2.  Instability of (methyl)ergometrine in tropical climates: an overview.

Authors:  H V Hogerzeil; G J Walker
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-10       Impact factor: 2.435

3.  Potency of ergometrine in tropical countries.

Authors:  G J Walker; H V Hogerzeil
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

4.  Stability of essential drugs during shipment to the tropics.

Authors:  H V Hogerzeil; A Battersby; V Srdanovic; N E Stjernstrom
Journal:  BMJ       Date:  1992-01-25
  4 in total
  8 in total

1.  The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999.

Authors:  Lamphone Syhakhang; Cecilia Stålsby Lundborg; Björn Lindgren; Göran Tomson
Journal:  Pharm World Sci       Date:  2004-12

Review 2.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  Uterotonic drug quality: an assessment of the potency of injectable uterotonic drugs purchased by simulated clients in three districts in Ghana.

Authors:  Cynthia Stanton; Alissa Koski; Patience Cofie; Ellie Mirzabagi; Breanne L Grady; Steve Brooke
Journal:  BMJ Open       Date:  2012-05-03       Impact factor: 2.692

4.  The quality of antimalarials available in Yemen.

Authors:  Ahmed Abdo-Rabbo; Amal Bassili; Hoda Atta
Journal:  Malar J       Date:  2005-06-29       Impact factor: 2.979

5.  Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India.

Authors:  Cynthia Stanton; Deepak Nitya Nand; Alissa Koski; Ellie Mirzabagi; Steve Brooke; Breanne Grady; Luke C Mullany
Journal:  BMC Pregnancy Childbirth       Date:  2014-11-13       Impact factor: 3.007

6.  Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability.

Authors:  Denis Kibira; Gaby Isabelle Ooms; Hendrika A van den Ham; Juliet Sanyu Namugambe; Tim Reed; Hubert Gm Leufkens; Aukje Mantel-Teeuwisse
Journal:  BMJ Open       Date:  2021-01-07       Impact factor: 2.692

7.  Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.

Authors:  Sachiko Ozawa; Hui-Han Chen; Yi-Fang Ashley Lee; Colleen R Higgins; Tatenda T Yemeke
Journal:  Am J Trop Med Hyg       Date:  2022-06-15       Impact factor: 3.707

8.  Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington
Journal:  JAMA Netw Open       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.